To examine the ability of Pim inhibitors to function in vivo to inhibit tumor growth and regulate IRS1 phosphorylation, we injected NSG mice with H-SB2, T-ALL cells expressing luciferase and administered AZD1208 by oral gavage. This evidence concerns the gene IRS1 and neoplasm.